bluebird bio, Inc.
General ticker "BLUE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $64.3M (TTM average)
bluebird bio, Inc. does not follow the US Stock Market performance with the rate: -15.5%.
Estimated limits based on current volatility of 1.2%: low 4.90$, high 5.02$
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.81$, 17.87$]
- 2025-12-31 to 2026-12-31 estimated range: [7.35$, 22.48$]
Financial Metrics affecting the BLUE estimates:
- Negative: Non-GAAP EPS, $ of -45.33 <= 0.04
- Negative: Operating cash flow per share per price, % of -76.04 <= 1.79
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of -6.85 <= 22.52
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -27.42 <= 0
- Negative: -0.28 < Industry inventory ratio change (median), % of 0
- Negative: negative Industry operating income (median)
Short-term BLUE quotes
Long-term BLUE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3.60MM | $29.50MM | $83.81MM |
| Operating Expenses | $290.69MM | $273.76MM | $354.27MM |
| Operating Income | $-287.09MM | $-244.26MM | $-270.46MM |
| Non-Operating Income | $20.63MM | $32.22MM | $29.82MM |
| Interest Expense | $6.32MM | $16.35MM | $22.58MM |
| R&D Expense | $240.76MM | $167.65MM | $94.25MM |
| Income(Loss) | $-266.46MM | $-212.04MM | $-240.65MM |
| Taxes | $0.12MM | $-0.13MM | $0.07MM |
| Profit(Loss)* | $-266.58MM | $-211.91MM | $-240.72MM |
| Stockholders Equity | $134.33MM | $194.54MM | $-31.53MM |
| Inventory | $1.41MM | $22.92MM | $65.02MM |
| Assets | $569.81MM | $619.16MM | $460.23MM |
| Operating Cash Flow | $-316.22MM | $-235.05MM | $-260.02MM |
| Capital expenditure | $13.21MM | $9.06MM | $2.60MM |
| Investing Cash Flow | $250.45MM | $154.95MM | $3.90MM |
| Financing Cash Flow | $17.52MM | $196.25MM | $87.47MM |
| Earnings Per Share** | $-3.39 | $-1.93 | $-24.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.